BlueRock Therapeutics to Present at 2018 Cell & Gene Meeting on the Mesa

BlueRock Therapeutics, LP, an engineered cell therapy company focused on leveraging its novel Cell+Gene platform to develop regenerative medicines for intractable diseases, today announced its participation in the Cell & Gene Meeting on the Mesa, to be held Oct. 3-5 in La Jolla, Calif.

Related News

Press Releases

BlueRock Therapeutics to Present at 2019 Cell & Gene Meeting on the Mesa

September 25, 2019
Press Releases

BlueRock Therapeutics to Participate at Upcoming Conferences

May 23, 2019
Press Releases

BlueRock Therapeutics to Present at 2019 Cell & Gene Meeting on the Mediterranean

April 18, 2019
Press Releases

BlueRock Therapeutics to Present at 2019 Cell & Gene Meeting on the Mesa

September 25, 2019
Press Releases

BlueRock Therapeutics to Participate at Upcoming Conferences

May 23, 2019
Press Releases

BlueRock Therapeutics to Present at 2019 Cell & Gene Meeting on the Mediterranean

April 18, 2019